VibeTech Events
Join us for events and community activities
Upcoming Events
Loading events...
Past Events
Loading events...
Leaders In Developing Physical Therapy Technology
Helping one patient at a time through therapeutic vibrations.
UPCOMING EVENTS
VibeTech’s Mission is to restore and enhance human quality of life by harnessing our world-class expertise in therapeutic vibration to provide cutting edge mobility innovations and solutions in healthcare.
VIBETECH SOLUTIONS
ABOUT VIBETECH
RECENT NEWS
February 3, 2026 Forward BIOLABS has announced the first round of awardees for its Innovation to Commercialization Pipeline (ICP) program , a new initiative designed to help early-stage biohealth companies across Wisconsin move closer to market readiness. The ICP program provides targeted, non-dilutive support to startups working to translate scientific innovation into commercial products. The program is aimed at companies navigating early commercialization challenges, including regulatory strategy, intellectual property development, scale-up planning and investment readiness. Forward BIOLABS announced that 18 emerging biohealth companies were selected in the program’s inaugural round. Each company received between $25,000 and $75,000 in non-dilutive funding, with award amounts tailored to the specific commercialization needs of each business. The selected companies span a wide range of biohealth sectors, including medical devices, diagnostics, biomanufacturing, life sciences, pharmaceuticals and radiopharmaceuticals. Collectively, the awardees reflect both Wisconsin’s established strengths in imaging and healthcare technologies and growing momentum in highly investable areas such as AI-enabled platforms and radiopharmaceutical development. ICP Round 1 awardees Archeus Technologies (Madison) – Developing radiopharmaceutical therapies and imaging agents for oncology. Arkayli Biopharma (Madison) – Developing targeted precision drug delivery for pediatric rare skin and vascular diseases. Axio Biopharma (Madison) – Building an AI-ready biologics CDMO with a cross-site data ecosystem. AyrFlo Innovation Labs (Madison) – Developing a noninvasive wearable breathing sensor to detect post-surgical deterioration. Crainosure (Madison) – Developing a smartphone app to help primary care providers screen infants for head shape differences. Estrigenix Therapeutics ( Milwaukee) – Developing drugs to treat symptoms associated with menopause. ImgGyd (Middleton) – Developing hardware and software for image-guided placement of minimally invasive brain electrodes and catheters. Immuto Scientific (Madison) – Building an automated, high-throughput platform for protein characterization in cells and solutions. Kivi Bio (Kenosha) – Supporting early-stage and scaling biohealth companies lacking access to biomanufacturing equipment. Phoenix-Aid (Madison) – Developing advanced wound care dressings using patented nanocomposite materials. Refined Sciences (Madison) – Specializing in bioprocessing components and assemblies for the biopharmaceutical industry. Retham Technologies (Milwaukee) – Developing a diagnostic test for heparin-induced thrombocytopenia to reduce patient risk. Roddy Medical (Milwaukee) – Developing medical line securement technology focused on improving patient safety. Sonoptima (Milwaukee) – Developing a wearable, AI-enabled ultrasound technology for radiation therapy timing. Soul Mobility (Oconomowoc) – Building mobility products for users in the complex rehabilitation wheelchair market. Stem Pharm (Fitchburg) – Developing small-molecule therapies for neuroinflammatory diseases, including Alzheimer’s disease. Varizymes (Middleton) – Developing rapid point-of-care molecular diagnostic reagents. Vibetech Enterprises (Sheboygan) – Developing rehabilitation technology to improve physical mobility and safe exercise access. Funding for the ICP program is supported through state-matched Wisconsin Biohealth Tech Hub funding under 2023 WI Act 96. The program is one of five initiatives that make up the Wisconsin Biohealth Tech Hub, which aims to strengthen the state’s biohealth ecosystem and accelerate company growth statewide. Awardees were selected through a competitive review process by the ICP Award Committee, a group of volunteer industry leaders from across Wisconsin’s biohealth and investment communities. The committee was led by Jessica Martin Eckerly , CEO and co-founder of Forward BIOLABS , and Lisa Johnson , CEO of BioForward Wisconsin, and included Brad Garcia , director of strategy and operations at AbbVie ; Elizabeth Hagerman , chief innovation officer at UW Health and executive director of the Isthmus Project ; Jay Hill , retired vice president of advanced technology at GE Healthcare ; Jenni Le , principal at Venture Investors Health Fund ; Jill Enos , managing partner at TitletownTech ; Justin Krause , vice president of global operations coordination and integrations at Exact Sciences ; Laura Hilty , principal at HealthX Ventures ; Nicolas Paris , CEO of Gilson ; and Sarah Duellman , biotech industry strategy and growth lead at Promega . Forward BIOLABS said the committee evaluated applications based on commercialization readiness, proposed use of funds and potential impact on Wisconsin’s biohealth sector. Martin Eckerly said the selected companies represent a group that is not only working in emerging areas of biohealth but also nearing key moments of commercial impact. “The winners here really include companies that are at the cutting edge of industry. They are the next wave of technologies,” she said. Several of the awardees are approaching regulatory milestones, scale-up decisions or initial commercialization efforts, making the ICP awards a timely form of support rather than a general infusion of capital. She added that the cohort reflects a broader strength of Wisconsin’s innovation ecosystem, where companies tend to focus on execution and technical progress before seeking visibility. She noted the ICP program is designed to support companies that are already doing the work and need targeted resources to move forward, reinforcing Wisconsin’s reputation as a place where biohealth innovations are built and validated. A second round of ICP awards is planned for 2026.
VibeTech is moving into the production phase of its VibeTech 3 therapeutic vibration device with assistance from Blitz Proto
The new WSCS program "Technology to Advance Healthy Communities" features (pictured left to right) Generations, Intergenerational Center Executive Director Jane Brill, VibeTech Founder and CEO Jeff Leismer and Rocky Knoll Health Care Center Life Enrichment Director Janine Bolz.
Parkinson’s disease is a progressive nervous system disorder that affects movement. The Accelerated Movement for Parkinson’s “AMP” Project out of Gregory Boxing is a boxing program designed for people with Parkinson’s to use physical and mental exercise to better manage their lives with the disease. According to The National Institute of Health (NIH), exercise and physical activity are believed to promote neural plasticity for individuals with Parkinson’s disease, along with the potential to slow the disease’s progression. Boxing for Parkinson’s disease has recently received increased attention across the globe. Along with the positive impact of the AMP Project, VibeTech’s VibeSitPRO portable therapeutic vibration rehabilitation device is well-suited for use by people living with Parkinson’s disease. For information on the AMP program, contact Marty Maibuecher at maibuecher@asmchicago.com.
SUBSCRIBE TO OUR NEWSLETTER
Join our newsletter and find out updates about VibeTech, New's publishings, and new advancements in therapeutic vibration.
Contact Us
STAY CONNECTED
© 2010-2026 VibeTech Enterprises. All Rights Reserved.